Rocket Lab Corp

RKLB remains in Stage 4 – Decline, characterized by clear lower highs and lower lows with bearish EMA alignment. The medium-term bias stays bearish, but price is extended below key EMAs and the 200 DMA on increasing distribution volume, reducing immediacy for new short entries. Execution should be deferred (Trim) into rallies toward the declining 9EMA/21EMA resistance zone for optimal engagement.

• ↑Q1 revenue $200.3M (+63.5% YoY)
• ↑Backlog at $2.2B underpins multi-year revenue
• ↓Q1 adjusted EBITDA loss $11.8M; FCF forecast -$114.2M